- Capital Cube•12 days ago
Categories: Yahoo Finance Get free summary analysis SurModics, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of SurModics, Inc. – Nektar Therapeutics, Thermo Fisher Scientific Inc., Heron Therapeutics Inc, Abbott Laboratories, pSivida Corp., Johnson & Johnson, PerkinElmer, Inc., Alkermes Plc and Agilent Technologies, Inc. (NKTR-US, TMO-US, ... Read more (Read more...)
- Business Wire•13 days ago
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and information systems and chief financial officer, will attend the 28th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, November 29, 2016....
- Zacks•18 days ago
SurModics' (SRDX) fourth-quarter of fiscal 2016 adjusted earnings of 26 cents per share beat the Zacks Consensus Estimate of 9 cents.
SRDX : Summary for Surmodics, Inc. - Yahoo Finance
Surmodics, Inc. (SRDX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||23.75 - 24.15|
|52 Week Range||17.45 - 30.75|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||31.25|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|